(1<i>R</i>,2<i>R</i>,6<i>S</i>)-2(4-(4-Isopropylbenzyl)piperazin-1-yl)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-enol
Parkinson’s disease (PD) is a progressive neurodegenerative disorder mainly characterized by movement dysfunction. Earlier, it was found that (1<i>R</i>,2<i>R</i>,6<i>S</i>)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol (Prottremin) demonstrated antiparkinsonian activity in vivo on different an...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2023-01-01
|
| coleção: | Molbank |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/1422-8599/2023/1/M1546 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|